Search

Your search keyword '"M C, Dalakas"' showing total 54 results

Search Constraints

Start Over You searched for: Author "M C, Dalakas" Remove constraint Author: "M C, Dalakas"
54 results on '"M C, Dalakas"'

Search Results

1. Fourth meeting of the European Neurological Society 25–29 June 1994 Barcelona, Spain

2. Predominant TCR-alpha beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies

3. Review: An update on inflammatory and autoimmune myopathies

12. Desmin myopathy

13. Effect of immunotherapy on expression of cytokines and chemokines in relation to beta-amyloid and ubiquitin in the muscles of patients with sporadic Inclusion Body Myositis (sIBM)

14. Understanding the immunopathogenesis of inclusion-body myositis: present and future prospects

15. Abnormal desmin protein in myofibrillar myopathies caused by desmin gene mutations

16. Sporadic cardiac and skeletal myopathy caused by a de novo desmin mutation

17. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines

19. Normal postexercise facilitation and depression of motor evoked potentials in postpolio patients

20. Fatigue: definitions, mechanisms, and paradigms for study

21. Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis

22. Safety and efficacy of strength training in patients with sporadic inclusion body myositis

23. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases

24. Mitochondrial and cellular toxicity induced by fialuridine in human muscle in vitro

25. Electrophysiologic and histologic studies in clinically unaffected muscles of patients with prior paralytic poliomyelitis

26. Strength gains without muscle injury after strength training in patients with postpolio muscular atrophy

28. Neuropathies in HIV infection

30. Common variable immunodeficiency and inclusion body myositis: a distinct myopathy mediated by natural killer cells

32. The effect of L-carnitine on the AZT-induced destruction of human myotubes. Part II: Treatment with L-carnitine improves the AZT-induced changes and prevents further destruction

33. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro

35. Retrovirus-related neuromuscular diseases

36. Retroviruses and inflammatory myopathies in humans and primates

37. Inflammatory and toxic myopathies

38. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model

39. Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature

41. Viral hide-and-seek in sporadic ALS: A new challenge

44. Nature of amyloid deposits in hypernephroma. Immunocytochemical studies in 2 cases associated with amyloid polyneuropathy

47. Thymosin alpha 1 in myasthenia gravis

48. Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy

50. Motor control in humans with large-fiber sensory neuropathy

Catalog

Books, media, physical & digital resources